• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Optimi Health Corp (OP: OPTHF )

    0.2368 -0.0072 (-2.95%)
    Streaming Delayed Price Updated: 1:13 PM EDT, Aug 2, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 27,508
    Open 0.2446
    Bid (Size) N/A (0)
    Ask (Size) N/A (0)
    Prev. Close 0.2440
    Today's Range 0.2335 - 0.2600
    52wk Range 0.1100 - 0.4300
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    New Milestone In Psychedelics Market: Canadian Start-Up Will Export Psilocybin And MDMA To Australia
    Canada Magic Mushrooms and MDMA market is hitting new milestones as canada has licensed Optimi to export psilocybin and MDMA to Australia 
    Via Benzinga
    Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More
    Via Benzinga

    Performance

    YTD
    +1.63%
    +1.63%
    1 Month
    +8.62%
    +8.62%
    3 Month
    -1.33%
    -1.33%
    6 Month
    -4.52%
    -4.52%
    1 Year
    +55.48%
    +55.48%

    More News

    Read More
    Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More
    Via Benzinga
    Optimi To Supply Psilocybin For New Zealand's Mātai Medical Research Institute
    Via Benzinga
    Two Top Biotechs Forge MDMA Supply Deals For Clinical Research
    Via Benzinga
    Psychedelics Headlines: Substitution Survey, Frank Herbert's Magic Mushrooms, Celestial Plans And News Review
    Via Benzinga
    Psychedelics Headlines: Predicting Readiness, Correcting The Hype, Good And Bad Drugs, Training Programs And More
    Via Benzinga
    Psychedelics Headlines: Anti-inflammatory Effects, Global Drug Survey, 'Synthetic Surprise,' UK's Harm Reduction Hub And More
    Via Benzinga
    Psychedelics Headlines: Magic Mushrooms For Sexual Wellbeing, The DEA's Stance, The Therapist's Role & More
    Via Benzinga
    Psyched: Psilocybin Therapy For Depression, UK Rescheduling, US Policy Reform And More
    Via Benzinga
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Optimi Health Will Supply Psychedelics To Canada's SAP, Secures CA$1M Private Financing
    Via Benzinga
    Psyched: Professional Practice Guidelines, DMT For Stroke, Dua Lipa &. Amanda Feilding, Clinical Results & More
    Via Benzinga
    Natural Psilocybin Companies Diversify: Latest By Optimi, Red Light Holland And A European Player
    Via Benzinga
    MDMA Deals: Optimi Supplies Numinus-MAPS Program & PharmAla Exports To Australian University
    Via Benzinga
    Psyched: New Psilocybin Forms, LSD Anxiety Study, UK's Parliamentary Debate And More
    Via Benzinga
    The Psychedelic Mushrooms Market; Between Legitimate Harvesting And Illegal Retail Sales
    Via Benzinga
    Psyched: $20M Research Fund, LSD Microdosing For Cancer, MEAI Enters Clinical Stage, Reform Update & More
    Via Benzinga
    Optimi Health Boosts Psilocybin Production With New Health Canada License And Supply Deal
    Via Benzinga
    What To Expect From The Benzinga Psychedelics Capital Conference, The Must-Attend Event For This Emerging Industry
    Via Benzinga
    Psyched: 9 US Reform Bills, Ayahuasca 'A Release' For Prince Harry, At-Home Therapy & More
    Via Benzinga
    Australia Receives First Batch Of Clinical-Grade Psilocybin From Mindset Pharma And PharmAla
    Via Benzinga
    Latest Psychedelics Deals: Optimi Supplies Australia, Awakn Partners Licensing In California
    Via Benzinga
    Psyched: 12 States Discuss Legalization Bills, Ceremonies For Veterans With TBI, Ketamine And MDMA Fast-Tracks & More
    Via Benzinga
    How Do Psilocybin And MDMA Work Together? This Proposed Experiential Study Is Set To Find Out
    Via Benzinga
    MDMA News: Optimi's New Drug Now Available, Revive Advances Transdermal Patch Evaluations
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.